Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
MCL1 is essential for the survival of stem and progenitor cells of multiple lineages, and is unique among pro-survival BCL2 family members in that it is rapidly turned over through the action of ubiquitin ligases. B- and mantle-cell lymphomas, chronic myeloid leukaemia, and multiple myeloma, however, express abnormally high levels of MCL1, contributing to chemoresistance and disease relapse. The mechanism of MCL1 overexpression in cancer is not well understood. Here we show that the deubiquitinase USP9X stabilizes MCL1 and thereby promotes cell survival. USP9X binds MCL1 and removes the Lys 48-linked polyubiquitin chains that normally mark MCL1 for proteasomal degradation. Increased USP9X expression correlates with increased MCL1 protein in human follicular lymphomas and diffuse large B-cell lymphomas. Moreover, patients with multiple myeloma overexpressing USP9X have a poor prognosis. Knockdown of USP9X increases MCL1 polyubiquitination, which enhances MCL1 turnover and cell killing by the BH3 mimetic ABT-737. These results identify USP9X as a prognostic and therapeutic target, and they show that deubiquitinases may stabilize labile oncoproteins in human malignancies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Phosphorylation of MCL1 at S159 and T163 also affects the USP9X-MCL1 interaction [121].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [121]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., & Tanaka, †. N. (2000) · Science · doi:10.1126/science.288.5468.1053 · Cited by 2,112
van Delft, M. F., Wei, A. H., Mason, K. D., Vandenberg, C. J., Chen, L., Czabotar, P. E., Willis, S. N., Scott, C. L., Day, C. L., Cory, S., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.027 · Cited by 1,240
Self-citationThe molecular classification of multiple myeloma
Zhan, F., Huang, Y., Colla, S., Stewart, J. P., Hanamura, I., Gupta, S., Epstein, J., Yaccoby, S., Sawyer, J., Burington, B., et al. (2006) · Blood · doi:10.1182/blood-2005-11-013458 · Cited by 1,133
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
Hummel, M., Bentink, S., Berger, H., Klapper, W., Wessendorf, S., Barth, T. F. E., Bernd, H.-W., Cogliatti, S. B., Dierlamm, J., Feller, A. C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055351 · Cited by 1,006
Maurer, U., Charvet, C., Wagman, A. S., Dejardin, E., & Green, D. R. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.02.009 · Cited by 881
Zhong, Q., Gao, W., Du, F., & Wang, X. (2005) · Cell · doi:10.1016/j.cell.2005.06.009 · Cited by 842
Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1
Opferman, J. T., Letai, A., Beard, C., Sorcinelli, M. D., Ong, C. C., & Korsmeyer, S. J. (2003) · Nature · doi:10.1038/nature02067 · Cited by 801
Cited by
Items 301–400 of 630
Cell Death and Deubiquitinases: Perspectives in Cancer
Bhattacharya, S., & Ghosh, M. K. (2014) · BioMed Research International · doi:10.1155/2014/435197 · Cited by 41
Wolfsperger, F., Hogh-Binder, S. A., Schittenhelm, J., Psaras, T., Ritter, V., Bornes, L., Huber, S. M., Jendrossek, V., & Rudner, J. (2016) · Cell Death and Disease · doi:10.1038/cddis.2015.405 · Cited by 41
Shang, Z., Zhao, J., Zhang, Q., Cao, C., Tian, S., Zhang, K., Liu, L., Shi, L., Yu, N., & Yang, S. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.007655 · Cited by 39
Warr, M. R., Mills, J. R., Nguyen, M., Lemaire‐Ewing, S., Baardsnes, J., Sun, K. L. W., Malina, A., Young, J. C., Jeyaraju, D. V., O'Connor‐McCourt, M. D., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.218321 · Cited by 37
The ubiquitin/proteasome system-dependent control of mitochondrial steps in apoptosis
Neutzner, A., Li, S., Xu, S., & Karbowski, M. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.03.019 · Cited by 40
Wensveen, F. M., Derks, I. A. M., van Gisbergen, K. P. J. M., de Bruin, A. M., Meijers, J. C. M., Yigittop, H., Nolte, M. A., Eldering, E., & van Lier, R. A. W. (2011) · Blood · doi:10.1182/blood-2011-09-378877 · Cited by 37
Regulating Fbw7 on the road to cancer
Xu, W., Taranets, L., & Popov, N. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.09.005 · Cited by 41
Role of deubiquitinases in DNA damage response
Le, J. P., Perez, E., Nemzow, L., & Gong, F. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.02.011 · Cited by 37
The Ubiquitin System: a Regulatory Hub for Intellectual Disability and Autism Spectrum Disorder
Kasherman, M. A., Premarathne, S., Burne, T. H. J., Wood, S. A., & Piper, M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01881-x · Cited by 45
Liu, X., Xu, B., Yang, J., He, L., Zhang, Z., Cheng, X. L., Yu, H., Liu, X., Jin, T. Y., Peng, Y., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.05.022 · Cited by 37
Deubiquitinases in hematological malignancies
Lei, H., Wang, J., Hu, J., Zhu, Q., & Wu, Y. (2021) · Biomarker Research · doi:10.1186/s40364-021-00320-w · Cited by 46
Context-dependent function of the deubiquitinating enzyme USP9X in pancreatic ductal adenocarcinoma
Cox, J. L., Wilder, P. J., Wuebben, E. L., Ouellette, M. M., Hollingsworth, M. A., & Rizzino, A. (2014) · Cancer Biology & Therapy · doi:10.4161/cbt.29182 · Cited by 38
MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies
Sionov, R. V. (2013) · ISRN Hematology · doi:10.1155/2013/348212 · Cited by 37
The X-linked deubiquitinase USP9X is an integral component of centrosome
Wang, Q., Tang, Y., Xu, Y., Xu, S., Jiang, Y., Dong, Q., Zhou, Y., & Ge, W. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.769943 · Cited by 38
Noack, S., Raab, M., Matthess, Y., Sanhaji, M., Krämer, A., Győrffy, B., Kaderali, L., El‐Balat, A., Becker, S., & Strebhardt, K. (2018) · Oncotarget · doi:10.18632/oncotarget.25386 · Cited by 35
Akiyama, H., Umezawa, Y., Ishida, S., Okada, K., Nogami, A., & Miura, O. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.03.046 · Cited by 35
Role of the ubiquitin proteasome system in hematologic malignancies
Sahasrabuddhe, A. A., & Elenitoba‐Johnson, K. S. J. (2014) · Immunological Reviews · doi:10.1111/imr.12236 · Cited by 40
Elevated expression of USP9X correlates with poor prognosis in human non-small cell lung cancer.
Wang, Y., Liu, Y., Yang, B., Cao, H., Yang, C., Ouyang, W., Zhang, S., Yang, G., Zhou, F., Zhou, Y., et al. (2015) · PubMed · doi:10.3978/j.issn.2072-1439.2015.04.28 · Cited by 36
Suzuki, J., Nakajima, W., Suzuki, H., Asano, Y., & Tanaka, N. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.037 · Cited by 37
Skowyra, A., Allan, L. A., Saurin, A. T., & Clarke, P. R. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.100 · Cited by 34
Mcl-1 Interacts with Akt to Promote Lung Cancer Progression
Chen, G., Park, D., Magis, A. T., Behera, M., Ramalingam, S. S., Owonikoko, T. K., Sica, G., Ye, K., Zhang, C., Chen, Z., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0950 · Cited by 35
MCL-1 is a clinically targetable vulnerability in breast cancer
Winder, M. L., & Campbell, K. J. (2022) · Cell Cycle · doi:10.1080/15384101.2022.2054096 · Cited by 38
Fan, F., Tonon, G., Bashari, M. H., Vallet, S., Antonini, E., Goldschmidt, H., Schulze‐Bergkamen, H., Opferman, J. T., Sattler, M., Anderson, K. C., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.09.042 · Cited by 34
Kinase-Independent Small-Molecule Inhibition of JAK-STAT Signaling
Chou, D. H., Vetere, A., Choudhary, A., Scully, S. S., Schenone, M., Tang, A. J., Gomez, R. C., Burns, S. M., Lundh, M., Vital, T., et al. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b04284 · Cited by 34
Balakrishnan, K., Burger, J. A., Fu, M., Doifode, T., Wierda, W. G., & Gandhi, V. V. (2014) · Neoplasia · doi:10.1016/j.neo.2014.10.002 · Cited by 36
Involvement of E3 Ligases and Deubiquitinases in the Control of HIF-α Subunit Abundance
Kubaichuk, K. I., & Kietzmann, T. (2019) · Cells · doi:10.3390/cells8060598 · Cited by 41
Li, J., Li, H., Zhu, W., Zhou, B., Ying, J., Wu, J., Zhang, H., Sun, H., & Gao, S. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14813 · Cited by 32
Dietachmayr, M., Rathakrishnan, A., Karpiuk, O., von Zweydorf, F., Engleitner, T., Fernández‐Sáiz, V., Schenk, P., Ueffing, M., Rad, R., Eilers, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15059-5 · Cited by 35
Kushwaha, D. S., O’Leary, C., Cron, K. R., Deraska, P. V., Zhu, K., D’Andrea, A. D., & Kozono, D. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2014.1002358 · Cited by 32
Targeting Deubiquitinating Enzymes in Glioblastoma Multiforme: Expectations and Challenges
Jin, W., Mao, X., & Qiu, G. (2016) · Medicinal Research Reviews · doi:10.1002/med.21421 · Cited by 34
Spermatogonial deubiquitinase USP9X is essential for proper spermatogenesis in mice
Kishi, K., Uchida, A., Takase, H. M., Suzuki, H., Kurohmaru, M., Tsunekawa, N., Kanai‐Azuma, M., Wood, S. A., & Kanai, Y. (2017) · Reproduction · doi:10.1530/rep-17-0184 · Cited by 32
WP1130 reveals USP24 as a novel target in T-cell acute lymphoblastic leukemia
Luo, H., Jing, B., Xia, Y., Zhang, Y., Meng, H., Cai, H., Tong, Y., Zhou, L., Yang, L. C., Yang, J., et al. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0773-6 · Cited by 35
Wang, T., Jing, B., Sun, B., Liao, Y., Song, H., Xu, D., Guo, W., Li, K., Hu, M. S., Liu, S., et al. (2019) · PubMed Central · Cited by 36
Through a glass less darkly: apoptosis and the germinal center response to antigen
Peperzak, V., Vikstrom, I. B., & Tarlinton, D. M. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01123.x · Cited by 37
Re-activation of mitochondrial apoptosis inhibits T-cell lymphoma survival and treatment resistance
Spinner, S., Crispatzu, G., Yi, J.-H., Munkhbaatar, E., Mayer, P., Höckendorf, U., Müller, N., Li, Z., Schader, T., Bendz, H., et al. (2016) · Leukemia · doi:10.1038/leu.2016.49 · Cited by 35
Li, Z., Cheng, Z., Chaerkady, R., Cui, Z., Liu, K., Li, X., Jiang, C., Jiang, W. I., Tan, M., Ni, X., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1226 · Cited by 31
Self-citationHan, K.-J., Wu, Z., Pearson, C. G., Peng, J., Song, K., & Liu, C. (2018) · Journal of Cell Science · doi:10.1242/jcs.221663 · Cited by 36
Recent Discovery and Development of Inhibitors that Target CDK9 and Their Therapeutic Indications
Zhang, Y., Shan, L., Tang, W., Ge, Y., Li, C., & Zhang, J. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00312 · Cited by 33
Cao, M.-N., Zhou, Y., Gao, A., Cao, J., Gao, L., Li, S., Xu, L., Su, M., Cao, X., Han, M., et al. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.02.006 · Cited by 33
Fu, P., Du, F., Liu, Y., Yao, M., Zhang, S., Zheng, X., & Zheng, S. (2017) · PubMed · Cited by 33
Rahmani, M., Aust, M. M., Hawkins, E., Parker, R. E., Ross, M., Kmieciak, M., Reshko, L. B., Rizzo, K., Dumur, C. I., Ferreira‐Gonzalez, A., et al. (2015) · Haematologica · doi:10.3324/haematol.2015.130351 · Cited by 32
Mechanisms of MCL-1 Protein Stability Induced by MCL-1 Antagonists in B-Cell Malignancies
Tantawy, S. I., Sarkar, A., Hubner, S., Tan, Z., Wierda, W. G., Eldeib, A., Zhang, S., Kornblau, S., & Gandhi, V. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-2088 · Cited by 34
Domostegui, A., Peddigari, S., Mercer, C. A., Iannizzotto, F., Rodríguez, M. L., Garcia‐Cajide, M., Amador, V., Diepstraten, S. T., Kelly, G. L., Salazar, R., et al. (2021) · Blood · doi:10.1182/blood.2020007452 · Cited by 37
Mei, Y., Stonestrom, A. J., Hou, Y., & Yang, X. (2010) · Protein & Cell · doi:10.1007/s13238-010-0107-x · Cited by 32
Targeting the Ubiquitin Proteasome System: Beyond Proteasome Inhibition
Xolalpa, W., Pérez‐Galán, P., Rodríguez, M. S., & Roué, G. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319220014 · Cited by 31
Tseng, H., Jiang, C. C., Croft, A. J., Tay, K. H., Thorne, R. F., Yang, F., Liu, H., Hersey, P., & Zhang, X. D. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0646 · Cited by 31
USP9X destabilizes pVHL and promotes cell proliferation
Zhang, C., Peng, Z., Zhu, M., Wang, P., Du, X., Li, X., Liu, Y., Jin, Y., McNutt, M. A., & Yin, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.11139 · Cited by 30
Ying, Z., Wang, H., & Wang, G. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319180013 · Cited by 32
Expansion of DUB functionality generated by alternative isoforms – USP35, a case study
Leźnicki, P., Natarajan, J., Bader, G., Spevak, W., Schlattl, A., Rehman, S. A. A., Pathak, D., Weidlich, S., Zoephel, A., Bordone, M. C., et al. (2018) · Journal of Cell Science · doi:10.1242/jcs.212753 · Cited by 29
Wu, L., Lin, Y., Feng, J., Qi, Y., Wang, X., Lin, Q., Shi, W., Zheng, E., Wang, W., Hou, Z., et al. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0936-5 · Cited by 32
Deng, J., Hou, G., Fang, Z., Liu, J., & Lv, X. (2019) · Oncology Letters · doi:10.3892/ol.2019.10883 · Cited by 28
Self-citationTambe, M., Karjalainen, E., Vähä-Koskela, M. J. V., Bulanova, D. R., Gjertsen, B. T., Kontro, M., Porkka, K., Heckman, C. A., & Wennerberg, K. (2020) · Leukemia · doi:10.1038/s41375-020-0972-0 · Cited by 29
Covalent Small Molecule Immunomodulators Targeting the Protease Active Site
Kim, H., Tagirasa, R., & Yoo, E. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00172 · Cited by 30
Peperzak, V., Slinger, E., ter Burg, J., & Eldering, E. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.105 · Cited by 29
Regulation of protein translation initiation in response to ionizing radiation
Trivigno, D., Bornes, L., Huber, S. M., & Rudner, J. (2013) · Radiation Oncology · doi:10.1186/1748-717x-8-35 · Cited by 30
Regulation of neuronal autophagy and cell survival by MCL1 in Alzheimer’s disease
Rezaeian, A.-H., Wei, W., & Inuzuka, H. (2022) · Acta Materia Medica · doi:10.15212/amm-2021-0002 · Cited by 32
Wang, X., Bao, Y., Dong, Z., Chen, Q., Guo, H., Ziang, C., & Shao, J. (2017) · Oncotarget · doi:10.18632/oncotarget.16931 · Cited by 28
PPPDE1 is a novel deubiquitinase belonging to a cysteine isopeptidase family
Xie, X., Wang, X., Jiang, D., Wang, J., Fei, R., Xu, C., Wei, L., Wang, Y., & Chen, H. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.04.161 · Cited by 29
Deubiquitinases: Pro-oncogenic Activity and Therapeutic Targeting in Blood Malignancies
Gutierrez-Diaz, B. T., Gu, W. J., & Ntziachristos, P. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.02.004 · Cited by 26
Non-coding RNAs Functioning in Colorectal Cancer Stem Cells
Fanale, D., Barraco, N., Listì, A., Bazan, V., & Russo, A. D. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-42059-2_5 · Cited by 26
Cellular demolition: Proteins as molecular players of programmed cell death
Dhuriya, Y. K., Sharma, D., & Naik, A. A. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.07.113 · Cited by 27
Genetic Events Inhibiting Apoptosis in Diffuse Large B Cell Lymphoma
Léveillé, E., & Johnson, N. A. (2021) · Cancers · doi:10.3390/cancers13092167 · Cited by 28
Sulkshane, P., Pawar, S. N., Waghole, R., Pawar, S. S., Rajput, P., Uthale, A., Oak, S., Kalkar, P., Wani, H., Patil, R., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01421-x · Cited by 26
Stabilization of MCL-1 by E3 ligase TRAF4 confers radioresistance
Li, M., Gao, F., Li, X., Gan, Y., Han, S., Yu, X., Liu, H., & Li, W. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05500-6 · Cited by 26
Polyubiquitination and proteasomal turnover controls the anti-apoptotic activity of Bcl-B
van de Kooij, B., Rooswinkel, R. W., Kok, F. K., Herrebout, M. A. C., de Vries, E., Paauwe, M., Janssen, G. M. C., van Veelen, P. A., & Borst, J. G. (2013) · Oncogene · doi:10.1038/onc.2013.99 · Cited by 30
Han, K.-J., Foster, D. G., Harhaj, E. W., Dzieciątkowska, M., Hansen, K. C., & Liu, C.-W. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw021 · Cited by 26
Liu, X., Yang, Y.-F., Fang, H.-Y., Wang, X., Zhang, M., & Wu, D.-C. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.07.001 · Cited by 24
Ubiquitin-Dependent Regulation of the Mammalian Hippo Pathway: Therapeutic Implications for Cancer
Nguyen, T., & Kugler, J. (2018) · Cancers · doi:10.3390/cancers10040121 · Cited by 26
SFI1 promotes centriole duplication by recruiting USP9X to stabilize the microcephaly protein STIL
Kodani, A., Moyer, T., Chen, A., Holland, A., Walsh, C. A., & Reiter, J. F. (2019) · Journal of Cell Biology · doi:10.1083/jcb.201803041 · Cited by 25
Guo, H., Zhang, X., Chen, Q., Bao, Y., Dong, C., & Wang, X. (2018) · PubMed Central · Cited by 26
The double life of MULE in preeclamptic and IUGR placentae
Rolfo, A., Garcia, J., Todros, T., Post, M., & Caniggia, I. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.44 · Cited by 30
The Role of Deubiquitinating Enzymes in Hematopoiesis and Hematological Malignancies
Sarodaya, N., Karapurkar, J. K., Kim, K.-S., Hong, S.-H., & Ramakrishna, S. (2020) · Cancers · doi:10.3390/cancers12051103 · Cited by 24
Roles of USP9X in cellular functions and tumorigenesis (Review)
Meng, Y., Hong, C., Yang, S., Qin, Z., Liu, Y., & Huang, Y. (2023) · Oncology Letters · doi:10.3892/ol.2023.14093 · Cited by 24
The ubiquitin-proteasomal system is critical for multiple myeloma: implications in drug discovery.
Cao, B., & Mao, X. (2011) · PubMed Central · Cited by 33
Liu, L., Yao, D., Zhang, P., Ding, W., Zhang, X., Zhang, C., Gong, S., Zhang, Y., Wang, J., Sun, T., et al. (2017) · Oncology Reports · doi:10.3892/or.2017.6050 · Cited by 27
Survival of midbrain dopamine neurons depends on the Bcl2 factor Mcl1
Robinson, E. J., Aguiar, S. P., Kouwenhoven, W. M., Starmans, D. S., von Oerthel, L., Smidt, M. P., & van der Heide, L. P. (2018) · Cell Death Discovery · doi:10.1038/s41420-018-0125-7 · Cited by 25
Role of Deubiquitinases in Parkinson’s Disease—Therapeutic Perspectives
Nielsen, P. Y., Okarmus, J., & Meyer, M. (2023) · Cells · doi:10.3390/cells12040651 · Cited by 25
Ubiquitin-specific peptidase 2a (USP2a) deubiquitinates and stabilizes β-catenin.
Kim, J., Naini, F. A., Sun, Y., & Ma, L. (2018) · Europe PMC (PubMed Central) · Cited by 24
Deubiquitinases in cell death and inflammation
Newton, K., & Gitlin, A. D. (2022) · Biochemical Journal · doi:10.1042/bcj20210735 · Cited by 26
Ubiquitin-Specific Proteases as Druggable Targets.
Davis, M. I., & Simeonov, A. M. (2015) · PubMed · Cited by 29
MCL-1 Is a Key Antiapoptotic Protein in Human and Rodent Pancreatic β-Cells
Meyerovich, K., Violato, N. M., Fukaya, M., Dirix, V., Pachera, N., Marselli, L., Marchetti, P., Strasser, A., Eizirik, D. L., & Cardozo, A. K. (2017) · Diabetes · doi:10.2337/db16-1252 · Cited by 27
Lu, Q., Lu, D., Shao, Z., & Li, D. (2019) · Cancer Science · doi:10.1111/cas.13953 · Cited by 24
Xiang, Y., Zhang, S., Lu, J., Zhang, W., Cai, M., Qiu, D., & Cai, D. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00094.2019 · Cited by 24
Bodur, Ç., Kütük, Ö., Karsli-Uzunbas, G., Isimjan, T. T., Harrison, P., & Başağa, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056369 · Cited by 29
Multiple Mechanisms Mediate Resistance to Sorafenib in Urothelial Cancer
Knievel, J., Schulz, W. A., Greife, A., Hader, C., Luebke, T., Schmitz, I., Albers, P., & Niegisch, G. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151120500 · Cited by 23
Tian, M., Zhu, R., Ding, F., & Liu, Z. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112188 · Cited by 24
Molecular mechanisms and clinical implications of miRNAs in drug resistance of colorectal cancer
Duan, L., Yang, W., Feng, W., Cao, L., Wang, X., Niu, L., Li, Y., Zhou, W. J., Zhang, Y., Liu, J., et al. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920947342 · Cited by 25
Self-citationPhysiological Functions of Mcl-1: Insights From Genetic Mouse Models
Chin, H. S., & Fu, N. Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.704547 · Cited by 22
Gao, H., Chen, Z., Zhao, L., Ji, C., & Xing, F. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189099 · Cited by 27
Ubiquitin at the crossroad of cell death and survival
Chen, Y.-S., & Qiu, X. (2013) · 癌症:英文版 · doi:10.5732/cjc.012.10283 · Cited by 29
Zou, Y., Qiu, G., Jiang, L., Cai, Z., Sun, W., Hu, H., Lu, C., Jin, W., & Hu, G. (2017) · Oncotarget · doi:10.18632/oncotarget.16447 · Cited by 23
Zhang, Y., Duan, C., Yang, J., Chen, S., Liu, Q. L., Zhou, L., Huang, Z., Xu, Y., & Xu, G. (2018) · Biochemical Journal · doi:10.1042/bcj20180005 · Cited by 25
Regulation of T cell differentiation and function by ubiquitin-specific proteases
Wang, A., Zhu, F., Liang, R., Li, D., & Li, B. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2019.103922 · Cited by 24
Wang, Y., Zhang, J., Wu, L., Liu, W., Wei, G., Gong, X., Liu, Y., Ma, Z., Ma, F., Thiery, J. P., et al. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1018-7 · Cited by 24
Golla, C., Bilal, M., Dwucet, A., Bader, N., Anthonymuthu, J., Heiland, T., Pruss, M., Westhoff, M., Siegelin, M. D., Capanni, F., et al. (2021) · Cancers · doi:10.3390/cancers13164123 · Cited by 22
MCL1 meets its end during mitotic arrest
Millman, S. E., & Pagano, M. (2011) · EMBO Reports · doi:10.1038/embor.2011.62 · Cited by 23
Deubiquitylating enzyme, USP 9X, regulates proliferation of cells of head and neck cancer lines
Nanayakkara, D. M., Nguyen, M. N., & Wood, S. A. (2016) · Cell Proliferation · doi:10.1111/cpr.12273 · Cited by 23
Zhou, M., Wang, T., Lai, H., Zhao, X., Yu, Q., Zhou, J., & Yang, Y. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.02.115 · Cited by 23
Costanzo, A. D., Gaudio, N. D., Conte, L., & Altucci, L. (2020) · Cancers · doi:10.3390/cancers12071898 · Cited by 24
Pro-apoptotic and anti-apoptotic regulation mediated by deubiquitinating enzymes
Choi, H., & Baek, K. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04132-5 · Cited by 28
Metadata
- Authors
- Schwickart, M., Huang, X., Lill, J. R., Liu, J., Ferrando, R., French, D. M., Maecker, H., O’Rourke, K., Bazan, F., Eastham-Anderson, J., Yue, P., Dornan, D., Huang, D. C. S., & Dixit, V. M.
- Affiliations
- Genentech (US)
- Walter and Eliza Hall Institute of Medical Research (AU)
- Corresponding author
- Dixit, Vishva M.
- Venue
- Nature
- Published
- 2009-12-20
- Volume
- 463
- Issue
- 7277
- Pages
- 103-107
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1991249033
- Cited by
- 628
- References
- 31
- Citations by year
- 2026: 18 · 2025: 21 · 2024: 20 · 2023: 21 · 2022: 20 · 2021: 38 · 2020: 41 · 2019: 44 · 2018: 45 · 2017: 45 · 2016: 51 · 2015: 49 · 2014: 50 · 2013: 46 · 2012: 44
- FWCI
- 15.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- USP9X, Mcl-1, deubiquitinase, protein stabilization, ubiquitination, multiple myeloma, Bcl-2 family proteins, apoptosis, ABT-737, BH3 mimetics, follicular lymphoma, diffuse large B-cell lymphoma, chemoresistance, therapeutic target, prognosis, proteasomal degradation, stem/progenitor cells, tumor cell survival
- MeSH terms
- Docetaxel, Animals, Biphenyl Compounds, Cell Line, Cell Survival, DNA Damage, Etoposide, Female, Half-Life, Humans, Lysine, Neoplasms, Nitrophenols, Phosphorylation, Piperazines, Prognosis, Protein Binding, Sulfonamides, Ultraviolet Rays, Gene Expression Regulation, Neoplastic, Mice, SCID, Apoptosis, Proto-Oncogene Proteins c-bcl-2, Xenograft Model Antitumor Assays, Polyubiquitin, RNA Interference, Ubiquitin Thiolesterase, Taxoids, Cell Line, Tumor, Mice, Ubiquitination, Protein Stability, Gene Knockdown Techniques, Myeloid Cell Leukemia Sequence 1 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.